Literature DB >> 2543432

Antibodies to human immunodeficiency virus type 1 in the urine specimens of HIV-1-seropositive individuals.

Y Z Cao1, B Hosein, W Borkowsky, M Mirabile, L Baker, D Baldwin, B J Poiesz, A E Friedman-Kien.   

Abstract

Specific antibodies to human immunodeficiency virus type 1 (HIV-1) were detected in 200-fold concentrated urine samples, but none were detected in unconcentrated urine specimens, from 100 randomly selected HIV-1--seropositive individuals by enzyme-linked immunosorbent assay (ELISA) and Western blot techniques using the manufacturer's recommended procedures. Using modified methods for both the ELISA and Western blot tests, antibodies to HIV-1 have also been detected in the unconcentrated urine specimens from the same HIV-1--seropositive individuals. No difference in the frequency of antibodies to HIV-1 were found between unconcentrated and 200-fold concentrated urine samples when tested by the modified methods. HIV-1 core antigen (p24) was not detected in either the concentrated or the unconcentrated HIV-1--seropositive adult urine samples; none of these individuals showed overt clinical or laboratory evidence of renal dysfunction. The titer of the antibodies to HIV-1 found in the urine specimens was found to be parallel with the titer of antibodies to HIV-1 in the corresponding individual's serum. Further elucidation of the pathophysiology and the nature of the specific antibodies to HIV-1 observed in the urine of HIV-1--seropositive individuals is under investigation in our laboratories.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543432     DOI: 10.1089/aid.1989.5.311

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Comparison of three assays for HIV antibodies detection in urine to be applied to epidemiological setting.

Authors:  A Carducci; B Casini; F Morleo; A Giuntini; M Parenti; R Moretti
Journal:  Eur J Epidemiol       Date:  1999-07       Impact factor: 8.082

Review 2.  More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.

Authors:  S Hashida; K Hashinaka; S Ishikawa; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Human immunodeficiency virus antibody testing by enzyme-linked fluorescent and western blot assays using serum, gingival-crevicular transudate, and urine samples.

Authors:  P M Martínez; A R Torres; R Ortiz de Lejarazu; A Montoya; J F Martín; J M Eiros
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

4.  Hepatitis E antibody profiles in serum and urine.

Authors:  M S Joshi; A M Walimbe; V A Arankalle; M S Chadha; S D Chitambar
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

5.  Urine samples as a possible alternative to serum for human immunodeficiency virus antibody screening.

Authors:  P Martínez; R O Lejarazu; J M Eiros; J D Benito; A Rodríguez-Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

6.  Evaluation of a commercial enzyme immunoassay for HIV screening in urine.

Authors:  J Almeda; J Casabona; L Matas; V González; R Muga; B Sanz; F Bolao; V Ausina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-08       Impact factor: 3.267

7.  Detection of anti-human immunodeficiency virus type 1 (HIV-1) immunoglobulin G in urine by an ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) with recombinant reverse transcriptase as an antigen.

Authors:  K Hashinaka; S Hashida; K Hirota; A Saitoh; A Nakata; H Shinagawa; S Oka; K Shimada; E Ishikawa
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.

Authors:  A S Vallari; R K Hickman; J R Hackett; C A Brennan; V A Varitek; S G Devare
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

9.  A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2.

Authors:  Svenja Weiss; Jéromine Klingler; Catarina Hioe; Fatima Amanat; Ian Baine; Erna Milunka Kojic; Jonathan Stoever; Sean Liu; Denise Jurczyszak; Maria Bermudez-Gonzalez; Viviana Simon; Florian Krammer; Susan Zolla-Pazner
Journal:  medRxiv       Date:  2020-04-17

10.  A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Svenja Weiss; Jéromine Klingler; Catarina Hioe; Fatima Amanat; Ian Baine; Suzanne Arinsburg; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Denise Jurczyszak; Maria Bermudez-Gonzalez; Viviana Simon; Florian Krammer; Susan Zolla-Pazner
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.